This story has been updated from a previous version to include comments made by Qiagen executives during its earnings call.

NEW YORK (GenomeWeb) – Qiagen said after the close of the market on Monday that its fourth quarter revenues grew 2 percent year over year, falling short of the analysts' average estimate.

Qiagen also said this week that Genomics England has selected the Qiagen Clinical Insights portfolio on behalf of th National Health Service in England to support the UK's program to sequence, analyze, and interpret 5 million genomes over the next five years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.